• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体抗炎芬那酸盐类药物抑制人类钠通道Nav1.7和Nav1.8。

Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.

作者信息

Sun Jian-Fang, Xu Yi-Jia, Kong Xiao-Hua, Su Yang, Wang Zhan-You

机构信息

College of Life and Health Sciences, Northeastern University, Shenyang, 110169, PR China.

School of Life Sciences and Biopharmaceutical Science, Shenyang Pharmaceutical University, Shenyang, 110016, PR China.

出版信息

Neurosci Lett. 2019 Mar 23;696:67-73. doi: 10.1016/j.neulet.2018.12.008. Epub 2018 Dec 5.

DOI:10.1016/j.neulet.2018.12.008
PMID:30528877
Abstract

Fenamates are N-substituted anthranilic acid derivatives, clinically used as nonsteroidal anti-inflammatory drugs (NSAIDs) in fever, pain and inflammation treatments. Previous studies have shown that they are also modulators of diverse ion channels, exhibiting either activation or inhibitory effects. However, the effects of fenamates on sodium channel subtypes are still unknown. In this study, fenamates, including mefenamic acid, flufenamic acid and tolfenamic acid, were examined by whole-cell patch clamp techniques on the sodium channels hNav1.7 and hNav1.8, which are closely associated with pain. The results showed that the mefenamic acid, flufenamic acid, and tolfenamic acid inhibited the peak currents of hNav1.7 and hNav1.8 in CHO cells stably expressing hNav1.7 and hNav1.8. However, much lighter inhibition effects of hNav1.8 were registered in the experimental system. Furthermore, the mefenamic acid, flufenamic acid and tolfenamic acid significantly affected the inactivation processes of hNav1.7 and hNav1.8 with I-V curves left-shifted to hyperpolarized direction. These data indicate that the inhibition effects of Nav1.7 and Nav1.8 by mefenamic acid, flufenamic acid and tolfenamic acid might contribute to their analgesic activity in addition to their inhibition of cyclooxygenase. These findings provide a basis for further studies in the discovery of other potential targets for NSAIDs.

摘要

芬那酸盐是N-取代邻氨基苯甲酸衍生物,临床上用作非甾体抗炎药(NSAIDs)来治疗发热、疼痛和炎症。先前的研究表明,它们也是多种离子通道的调节剂,具有激活或抑制作用。然而,芬那酸盐对钠通道亚型的影响仍不清楚。在本研究中,采用全细胞膜片钳技术,研究了包括甲芬那酸、氟芬那酸和托芬那酸在内的芬那酸盐对与疼痛密切相关的钠通道hNav1.7和hNav1.8的作用。结果表明,甲芬那酸、氟芬那酸和托芬那酸抑制了稳定表达hNav1.7和hNav1.8的CHO细胞中hNav1.7和hNav1.8的峰值电流。然而,在实验系统中,hNav1.8的抑制作用要轻得多。此外,甲芬那酸、氟芬那酸和托芬那酸显著影响hNav1.7和hNav1.8的失活过程,I-V曲线向左移向超极化方向。这些数据表明,甲芬那酸、氟芬那酸和托芬那酸对Nav1.7和Nav1.8的抑制作用,除了抑制环氧化酶外,可能还有助于它们的镇痛活性。这些发现为进一步研究发现NSAIDs的其他潜在靶点提供了基础。

相似文献

1
Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.非甾体抗炎芬那酸盐类药物抑制人类钠通道Nav1.7和Nav1.8。
Neurosci Lett. 2019 Mar 23;696:67-73. doi: 10.1016/j.neulet.2018.12.008. Epub 2018 Dec 5.
2
Fenamates Inhibit Human Sodium Channel Nav1.2 and Protect Glutamate-Induced Injury in SH-SY5Y Cells.非甾体抗炎芬那酸类药物抑制人钠通道Nav1.2并保护SH-SY5Y细胞免受谷氨酸诱导的损伤。
Cell Mol Neurobiol. 2020 Nov;40(8):1405-1416. doi: 10.1007/s10571-020-00826-1. Epub 2020 Mar 11.
3
Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.来自狼蛛Thrixopelma pruriens毒液的新型电压门控钠通道抑制剂ProTx-III [μ-TRTX-Tp1a]的鉴定与表征
Mol Pharmacol. 2015 Aug;88(2):291-303. doi: 10.1124/mol.115.098178. Epub 2015 May 15.
4
Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Na1.7.氯丙嗪对人类疼痛阈值钠通道Na1.7的抑制机制。
Neurosci Lett. 2017 Feb 3;639:1-7. doi: 10.1016/j.neulet.2016.12.051. Epub 2016 Dec 22.
5
Trp: a conserved aromatic residue crucial to the interaction of a scorpion peptide with sodium channels.色氨酸:一种保守的芳香族残基,对蝎肽与钠离子通道的相互作用至关重要。
J Biochem. 2020 Dec 26;168(6):633-641. doi: 10.1093/jb/mvaa088.
6
Regulatory effects of non-steroidal anti-inflammatory drugs on cardiac ion channels Nav1.5 and Kv11.1.非甾体抗炎药对心脏离子通道 Nav1.5 和 Kv11.1 的调节作用。
Chem Biol Interact. 2021 Apr 1;338:109425. doi: 10.1016/j.cbi.2021.109425. Epub 2021 Feb 19.
7
Structure-activity relationship of fenamates as Slo2.1 channel activators.芳基乙酸酯类作为 Slo2.1 通道激活剂的构效关系。
Mol Pharmacol. 2012 Nov;82(5):795-802. doi: 10.1124/mol.112.079194. Epub 2012 Jul 31.
8
Antidepressants inhibit Na1.3, Na1.7, and Na1.8 neuronal voltage-gated sodium channels more potently than Na1.2 and Na1.6 channels expressed in Xenopus oocytes.抗抑郁药抑制 Na1.3、Na1.7 和 Na1.8 神经元电压门控钠离子通道的效力强于在非洲爪蟾卵母细胞中表达的 Na1.2 和 Na1.6 通道。
Naunyn Schmiedebergs Arch Pharmacol. 2017 Dec;390(12):1255-1270. doi: 10.1007/s00210-017-1424-x. Epub 2017 Sep 14.
9
Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin.利用独特的有效钠通道激动剂安替毒素开发用于鉴定hNav1.7拮抗剂的快速通量测定法。
Mar Drugs. 2016 Feb 16;14(2):36. doi: 10.3390/md14020036.
10
A mutant of the Karsch antitumor-analgesic peptide exhibits reduced inhibition to hNa1.4 and hNa1.5 channels while retaining analgesic activity.卡尔施抗肿瘤镇痛肽的一种突变体对hNa1.4和hNa1.5通道的抑制作用减弱,同时保留了镇痛活性。
J Biol Chem. 2017 Nov 3;292(44):18270-18280. doi: 10.1074/jbc.M117.792697. Epub 2017 Sep 18.

引用本文的文献

1
Anesthetic- and Analgesic-Related Drugs Modulating Both Voltage-Gated Na and TRP Channels.调节电压门控钠通道和瞬时受体电位通道的麻醉和镇痛相关药物。
Biomolecules. 2024 Dec 18;14(12):1619. doi: 10.3390/biom14121619.
2
Photolysis of tolfenamic acid in aqueous and organic solvents: a kinetic study.托芬那酸在水性和有机溶剂中的光解:一项动力学研究。
RSC Adv. 2024 Jul 8;14(30):21383-21397. doi: 10.1039/d4ra01369g. eCollection 2024 Jul 5.
3
Antiseizure properties of fenamate NSAIDs determined in mature human stem-cell derived neuroglial circuits.
在成熟的人类干细胞衍生神经胶质细胞回路中确定的非甾体抗炎药(NSAIDs)的抗癫痫特性。
Front Pharmacol. 2024 May 16;15:1385523. doi: 10.3389/fphar.2024.1385523. eCollection 2024.
4
Phylogenetic Analysis Provides Insight Into the Molecular Evolution of Nociception and Pain-Related Proteins.系统发育分析为伤害感受和疼痛相关蛋白的分子进化提供了见解。
Evol Bioinform Online. 2023 Dec 14;19:11769343231216914. doi: 10.1177/11769343231216914. eCollection 2023.
5
Use-Dependent Relief of Inhibition of Nav1.8 Channels by A-887826.A-887826 对 Nav1.8 通道抑制的使用依赖性缓解。
Mol Pharmacol. 2023 Apr;103(4):221-229. doi: 10.1124/molpharm.122.000593. Epub 2023 Jan 12.
6
Polymer-supported synthesis of -substituted anthranilates as the building blocks for preparation of -arylated 3-hydroxyquinolin-4(1)-ones.聚合物负载合成α-取代邻氨基苯甲酸酯作为制备α-芳基化3-羟基喹啉-4(1H)-酮的构建单元。
RSC Adv. 2021 Mar 2;11(16):9362-9365. doi: 10.1039/d1ra01308d. eCollection 2021 Mar 1.
7
Fenamates as Potential Therapeutics for Neurodegenerative Disorders.非甾体类抗炎药类作为神经退行性疾病的潜在治疗药物。
Cells. 2021 Mar 22;10(3):702. doi: 10.3390/cells10030702.
8
Inhibition of Fast Nerve Conduction Produced by Analgesics and Analgesic Adjuvants-Possible Involvement in Pain Alleviation.镇痛药及镇痛佐剂对快速神经传导的抑制作用——与疼痛缓解可能的关联
Pharmaceuticals (Basel). 2020 Apr 5;13(4):62. doi: 10.3390/ph13040062.
9
Fenamates Inhibit Human Sodium Channel Nav1.2 and Protect Glutamate-Induced Injury in SH-SY5Y Cells.非甾体抗炎芬那酸类药物抑制人钠通道Nav1.2并保护SH-SY5Y细胞免受谷氨酸诱导的损伤。
Cell Mol Neurobiol. 2020 Nov;40(8):1405-1416. doi: 10.1007/s10571-020-00826-1. Epub 2020 Mar 11.